Acro Biomedical Co., Ltd.
ACBM· OTC
ACBMAcro Biomedical Co., Ltd.
Filed May 22, 2017 · 10-Q · 52 days after period end · 0001640334-17-001056
| Metric | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|
| Net Income | -$22.44K | -$6.35K | -$29.00 |
| EPS Diluted | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Acro Biomedical Co., Ltd. · CIK 1622996 · Engraved from SEC EDGAR
ended Mar 31, 2017 · filed May 22, 2017 · 52 d after period end
